Nuparp 200mg Tablet USA | Bulk Oncology Exporter from India

Nuparp 200mg Tablet: Precision PARP Inhibitor for Advanced Oncology Care

Are you searching for a reliable Nuparp 200 mg tablet exporter from India? Ernest Oncology, a specialized division of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of advanced targeted therapies. We maintain a high-authority, regulatory-compliant supply chain serving the USA, UK, Australia, and South Africa, ensuring that life-saving medications reach healthcare providers with pharmaceutical-grade integrity and efficient global logistics.

Detailed Product Overview: What is Nuparp 200 mg?

Nuparp 200 mg is a high-potency oral targeted therapy containing the active pharmaceutical ingredient Niraparib. It belongs to a sophisticated class of medications known as PARP (Poly ADP-ribose polymerase) inhibitors.

Specifically designed to treat cancers with DNA repair deficiencies, Nuparp 200 mg is a precision-engineered medication that exploits the genetic vulnerabilities of cancer cells. Manufactured by BDR Pharmaceuticals, Nuparp 200mg offers a world-class, cost-effective alternative for international B2B procurement, meeting stringent international standards for quality and clinical efficacy.

Primary Therapeutic Indications

Nuparp 200 mg Tablet is clinically indicated for the management of:

1. Ovarian Cancer Maintenance: For adult patients with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to first-line platinum-based chemotherapy.

2. Recurrent Cancer: Maintenance treatment for adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy.

3. Advanced HRD-Positive Cancer: Treatment of adult patients with advanced ovarian cancer who have been treated with three or more prior chemotherapy regimens and whose cancer is associated with homologous recombination deficiency (HRD) positive status.

Mechanism of Action: How Nuparp 200mg Works

Nuparp (Niraparib) works by targeting the DNA repair mechanisms within cancer cells:

• PARP Enzyme Inhibition: PARP enzymes (PARP-1 and PARP-2) play a critical role in repairing single-strand breaks in DNA. Nuparp binds to these enzymes, preventing them from performing their repair functions.

• Synthetic Lethality: In cancer cells that already have deficiencies in other DNA repair pathways (like BRCA mutations or HRD), the inhibition of PARP leads to the accumulation of double-strand DNA breaks.

• Cellular Death: Because the cancer cell cannot repair these double-strand breaks, it undergoes genomic instability and eventual apoptosis (programmed cell death), while normal cells with healthy repair pathways are less affected.

Administration and Safety Guidelines

• Standard Dosage: The typical dose is 200 mg (one tablet) taken orally once daily at the same time each day, with or without food. Dosage may be adjusted based on body weight or baseline platelet count.

• Instructions: Tablets must be swallowed whole. Do not chew, crush, or split the tablets. Taking the dose at bedtime may help manage potential nausea.

• Key Precautions:

• Hematologic Monitoring: Nuparp can cause a decrease in blood cell counts (neutropenia, anemia, and thrombocytopenia). Weekly blood counts are required during the first month of treatment.

• Hypertension Management: Patients should monitor their blood pressure regularly, as Niraparib can cause increases in blood pressure and heart rate.

• Myelodysplastic Syndrome (MDS): Patients should be monitored for signs of bone marrow problems, which, while rare, are a serious potential side effect.

• Embryo-Fetal Toxicity: Nuparp can cause fetal harm. Effective contraception is mandatory for female patients during and for at least six months after the final dose.

Why Source Nuparp 200 mg from Ernest Oncology?

• Strategic Indian Exporter: Direct access to BDR Pharmaceuticals’ manufacturing excellence, ensuring 100% authenticity and competitive bulk pricing for the international market.

• Logistics Mastery: Expertise in navigating the regulatory and customs landscapes of the USA, UK, Australia, and South Africa.

• Bulk Supply Reliability: We specialize in fulfilling large-scale orders for oncology hospitals, specialty clinics, and regional distributors, ensuring treatment stability.

• Regulatory Compliance: Every shipment is accompanied by a Certificate of Analysis (COA) and verified documentation to facilitate seamless global customs clearance.